登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRxiv，3月9日，Comparison of severe and non-severe COVID-19 pneumonia: review and meta-analysis》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-10

  • Comparison of severe and non-severe COVID-19 pneumonia: review and meta-analysis

    Weiping Ji, Jing Zhang, Gautam Bishnu, Xudong Du, Xinxin Chen, Hui Xu, Xiaoling Guo, Zhenzhai Cai, Xian Shen

    doi: https://doi.org/10.1101/2020.03.04.20030965

    Abstract

    Objective: To compare the difference between severe and non-severe COVID-19 pneumonia and figure out the potential symptoms lead to severity. Methods: Articles from PubMed, Embase, Cochrane database, and google up-to 24 February 2020 were systematically reviewed. Eighteen Literatures were identified with cases of COVID-19 pneumonia. The extracted data includes clinical symptoms, age, gender, sample size and region et al were systematic reviewed and meta analyzed. Results: 14 eligible studies including 1,424 patients were analyzed. Symptoms like fever (89.2%), cough (67.2%), fatigue (43.6%) were common, dizziness, hemoptysis, abdominal pain and conjunctival congestion/conjunctivitis were rare.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.03.04.20030965v1
91浏览量
原文链接
相关报告

  • 《MedRxiv，3月16日，Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-17
    • Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection Vageesh Jain, Jin-Min Yuan doi: https://doi.org/10.1101/2020.03.15.20035360 Abstract Background/introduction COVID−19, a novel coronavirus outbreak starting in China, is now a rapidly developing public health emergency of international concern. The clinical spectrum of COVID−19 disease is varied, and identifying factors associated with severe disease has been described as an urgent research priority. It has been noted that elderly patients with pre-existing comorbidities are more vulnerable to more severe disease. However, the specific symptoms and comorbidities that most strongly predict disease severity are unclear. We performed a systematic review and meta-analysis to identify the symptoms and comorbidities predictive of COVID−19 severity. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    76浏览量
    原文链接

  • 《IJID，3月12日，Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-13
    • Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis JingYang, YaZheng, XiGou, KePu, ZhaofengChen, QinghongGuo, RuiJi, HaojiaWang, YupingWang, YongningZhou Show more https://doi.org/10.1016/j.ijid.2020.03.017 Abstract Background An outbreak of Novel Coronavirus (COVID -19) in Wuhan, China, the epidemic is more widespread than initially estimated, with cases now confirmed in multiple countries. Aims The aim of the meta-analysis was to assess the prevalence of comorbidities in the COVID-19 infection patients and the risk of underlying diseases in severe patients compared to non-severe patients.
    202浏览量
    原文链接